To address whether SCFAs improved HF symptoms and which SCFAs were the most effective, we provided primary data concerning the direct effects of acetate, propionate, and/or butyrate on alleviating TGF-β1-induced LX2 cell activation. The gene discussed is TGFB1; the disease is hydrops fetalis.